Volume 53, Issue 3 pp. 681-685
Full Access

Dual Effects of K+ Depoiarisation on Inositol Polyphosphate Production in Rat Cerebral Cortex

John G. Baird

John G. Baird

Department of Pharmacology-and Therapeutics, University of Leicester, Leicester, England

Search for more papers by this author
Stefan R. Nahorski

Corresponding Author

Stefan R. Nahorski

Department of Pharmacology-and Therapeutics, University of Leicester, Leicester, England

Address correspondence and reprint requests to Prof. S. R. Nahorski at Department of Pharmacology and Therapeutics, University of Leicester. P.O. Box 138, Medical Sciences Building, University Road, Leicester LE1 9HN, U.K.Search for more papers by this author
First published: September 1989
Citations: 23

Abstract

Depoiarisation of [3H]inosito]-prelabejled slices of rat cerebral cortex with elevated extracellular Kr induced a rapid and marked increase in inositol polyphosphate accumulation. Addition of the muscarinic antagonist atropine (10 μM) markedly inhibited the K+-induced accumulation of inositol tetrakisphosphate (InsP4), with only a slight reduction in stimulated inositol bis- and trisphosphate levels. Inhibitory effects on InsP4 were noted at the earliest time period measured (30 s) and suggested the involvement of released endogenous acetylcholine in part of the response. The atropine-insensitive component of depoiarisation did not! appear to be secondary to release of noradrenaline, histamine, or 5-hydroxytryptamine, because addition of prazosip, mepyr-amine, or ketanserin was without effect on the K+ response. Furthermore, secretion of a neuropeptide that could stimulate phosphoinositide hydrolysis was unlikely, because the peptidase inhibitor bacitracin was also without effect. The results suggest that endogenous acetylcholine can stimulate phosphoinositide metabolism by interacting with muscarinic receptors and that this is particularly evident on InsP4 accumulation. Atropine-insensitive responses may be secondary to Ca2+ entry via voltage-sensitive channels.

Abbreviations used:

  • InsP1
  • inositol monophosphate
  • InsP2
  • inositol bisphosphate
  • InsP3
  • inositol trisphosphate
  • Ins(l
  • ,5)P3, inositol 1,4,5-trisphosphate
  • InsP4
  • inositol tetrakisphosphate
  • Ins(l
  • ,4,5)P4, inositol 1,3,4,5-tetrakisphosphate
  • PtdlnsP
  • phosphatidylinositol 4-phosphate
  • PtdInsP2
  • phosphatidylinositol 4,5-bisphosphate
    • The full text of this article hosted at iucr.org is unavailable due to technical difficulties.